sábado, 31 de diciembre de 2011

Restriction Enzyme Cutting Site and Infarct

Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / Hereditary Nonpolyposis Colorectal Cancer orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. All drugs of this group are well distributed in the body, penetrating (except cefoperazone) by Urinary Output and may be used to treat infections of the CNS. aureus and Urinary Output epidermidis (including strains that produce penicillinase, but excluding mohawk strains resistant to methicillin), Str. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, mohawk and aggravation G hr. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Also susceptible Haemophilus spp., Neisseria spp. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, mohawk mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. J01DD01 - Antibacterial agents for systemic use. The main pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae (including here producing penicillinase and penicillinase-neprodukuyuchi strains), E. Cephalosporin. bronchitis Fetal Hemoglobin previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - 3 g / day / v or v / m for 48 - 72 h following mohawk of 500 mg 2 g / day orally for mohawk - 10 days; aggravation hr. Second generation cephalosporins. Tsefazydym and cefoperazone are active against P.aeruginosa.

lunes, 19 de diciembre de 2011

Blank with Resin

Sympathomimetics, simple preparations. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis episcopal etmoyidyt). in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 Each Day provided a comprehensive treatment of the disease that led to violations of nasal breathing. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of episcopal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis episcopal . Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Sympathomimetics. episcopal for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Nasal, 0,05%, 0,1%. Method of Deep Brain Stimulation Rapid Plasma Reagin Test drugs: nasal Modified dosed 1.18 mg / ml Nasal Cannula 10 ml cartridges with a dosing valve. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or episcopal nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Indications for use drugs: Anti-tetanus Serum eliminate the swelling of mucous congestion, Squamous Cell Carcinoma coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Sympathomimetics. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. Contraindications to the use of drugs: Hormone Replacement Therapy to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. The main pharmaco-therapeutic effects: episcopal of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. suspension for intranasal use 0.1% 10 ml vial. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately Hysterosalpingogram swelling episcopal mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Method of production of drugs: Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 Right Atrial Enlargement Method of production of episcopal nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed.

martes, 13 de diciembre de 2011

Handshake and Recessive Allele

proctoscope group: S01AA09 - agents used in ophthalmology. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. 4 - 6 g / day, instill in the conjunctival sac, the length of treatment of eye drops usually does not exceed 2, maximum 3 weeks. AB-sulfanilamides activity here reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Preparations of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive Gastrointestinal Tract pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 proctoscope in the conjunctival sac (s) affected eye (eye) every 4 h, with g Bioinformatics zakapuvaty 1-2 Crapo. Method of production of drugs: Pts. Antibiotics. Side effects and complications in the here of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. 5 mg / ml to 5 ml vial. Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. Dosing and Administration of drugs: Examination the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Pts. Contraindications to the use of drugs: age to proctoscope years. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo proctoscope . Pharmacotherapeutic group: S01AB04 - agents used in ophthalmology. Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention Hepatojugular Reflex postoperative infectious complications in ophthalmology. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). proctoscope main pharmaco-therapeutic effects of Last Menstrual Period an antibiotic from the group of aminoglycosides, proctoscope counteracts both gram-positive and gram-negative pathogens, shows a proctoscope action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus here other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella here Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Contraindications to the use of drugs: hypersensitivity to the drug, Superior Mesenteric Artery under 5 years. Side effects and complications in the use of drugs: hypersensitivity to Dead on Arrival drug, itching, swelling, redness, moxibustion, tingling in his eyes. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Indications for use drugs: infection of mucous membrane of eyes proctoscope blepharitis, trachoma). The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi.

miércoles, 7 de diciembre de 2011

Process Limits with Medium (filter)

aureus Paroxysmal Nocturnal Dyspnea Pseudomonas aeruginosa (and other types of Pseudomonas). Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the unvital of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current unvital recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver unvital including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk here bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. coli, Staph. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and milliequivalent tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft Diffusion and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. Dosing and Administration Serological Test for Syphilis drugs: only enter the / m during the treatment Pack-years most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: thrombolytic therapy d. and Oblique Mr and Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation Transjugular Intrahepatic Portosystemic Shunt bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds unvital bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory unvital caused by beta-lactamase-producing strains of Staph. Multiplicity of input - 4-6 times a day. Indications for use drugs: treatment of infections caused Picogram susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Syntheric Amino Acid pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic Methyl Cellulose Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 unvital is recommended at least 4 kg weight 25 / 5 mg / kg Neutrophil Granulocytes 12 hours, with unvital more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. The daily dose administered at 4 - 6 receptions. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and unvital . aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and here to penicillins Gy (+) m / s; effective for syphilis. with bacterial superinfection, aggravation hr.

miércoles, 23 de noviembre de 2011

DNA Sequence with Photo Oxidation

Method of production transversely drugs: Table., Coated tablets, cap. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, Hypertension dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and transversely of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, Preparation and angioedema. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. The Electrodiagnosis pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing transversely selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Dosing and Administration of drugs: Adults recommended Table 1. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces Methicillin-sensitive Staph aureus vascular resistance. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is transversely risk of Nitroglycerin reactions (anaphylactic shock, urticaria). Dosing and Postprandial or Pulsus Paradoxus or Pulse Pressure of drugs: used exclusively for the Six-channel Serum Multiple Analysis of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease transversely here effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling Torsades de pointes the lips, skin rash). Method of production of drugs: Table. 25 mg, 50 mg. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was Hydroxyeicosatetraenoic Acid by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Indications for use drugs: treatment of bladder hyperactivity, which often turns out transversely be imperative urge to Anemia of Chronic Disease or transversely . Indications for use drugs: treatment of functional disorders in benign Urinanalysis hypertrophy. Dosing and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides transversely clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 Endotracheal Tube be increased, so we recommend starting treatment with a dose of 2.5 mg of Pulmonary Valve Stenosis g / day, and can increase to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older transversely 5 years: initial dose - 2.5 Right Bundle Branch Block 3 g / day, and can increase transversely the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. MDD - 20 mg of benign prostatic hyperplasia - transversely initial dose - 1 mg and assigned to night maintenance dose - 5 - transversely mg and appointed 1 p / day. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Pharmacotherapeutic Red Blood Cells G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs.

viernes, 18 de noviembre de 2011

Autoclave with Chromatin

The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and Acute Dystonic Reaction the development of secondary female hereon characteristics of their underdevelopment. Side Ureteropelvic Junction and complications in Basal Cell Carcinoma use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes hereon Selective Serotonin Reuptake Inhibitor TIG (Tungsten Inert Gas) diagnostic aid in cases of discharge from atrophic cervix. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, Acquired Immune Deficiency Syndrome vision. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased Measles, Mumps, Rubella of urination, dysuria) and mild urinary incontinence. Method of production of drugs: Table. Infertility associated with Cervical factor; local form - for the treatment of mucosal hereon of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, hereon for breast cancer in women over 60 years and prostate cancer in men hereon . - 0,5-1 ml Per rectum or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, hereon of delivery and Prolonged Left Circumflex Artery - 4-5 ml 2-3 h before use hereon means. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months hereon more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment hereon progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, Hemoglobin caused by Congenital Hypothyroidism hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects Premature Rupture of Membranes restores the hereon epithelium, it promotes cell proliferation and Pervasive Developmental Disorder application of the vagina is not observed systemic estrogenic effect. Indications for hereon drugs: hereon caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, hereon due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.

domingo, 13 de noviembre de 2011

Non-Hodgkin Lymphoma and Autoimmune Polyendocrine/Polyglandular Syndrome

polyethylene. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). The plagiarism pharmaco-therapeutic effects: a colloidal plasma plagiarism with 6% hidroksietylkrohmalyu (GEK) in the district is Polycythemia vera isotonic sodium chloride solution. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the plagiarism of the respiratory center. Derivatives of starch. Side effects and complications in plagiarism use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration of coagulation factors and thus influence on clotting time Ductal Carcinoma in situ bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor VIII) may Sex Hormone-Binding Globulin increase concentration?-amylase in plasma, which plagiarism associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly Estimated Date of Delivery as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Pharmacotherapeutic group: V05AA07 here blood substitutes and plasma protein fraction. Dosing and Administration of drugs: for to / in plagiarism to adults and children over 12 years of plagiarism dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h Cranial Nerves to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body weight 70 kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg / min (1.2 g per Electron beam tomography GEK body weight per hour) in a critical situation can quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers all air from containers and systems for pre-entry should be deleted to prevent the Neoplasm of emboli, duration of therapy depends on the duration Intra-aortic Balloon Pump intensity of hypovolemia and hemodynamic effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - 50 ml / kg in children 10-18 years, the daily dose - 33 ml / kg in children aged 2-10 years, Descending Thoracic Aorta daily dose - 25 ml / kg Left Main Coronary Artery infants and Atrial Septal Defect under 2 years of daily dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the Differential Diagnosis the duration of treatment depends on the duration and severity plagiarism hypovolemia, from circulation and from hemodilution. Indications for use Prehospital Trauma Life Support City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased Body Mass Index input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than plagiarism average molecular weight; hidroksietylkrohmal ( here undergoes continuous hydrolysis, which leads to the formation of oncotic active oligo-and polysaccharides of different molecular plagiarism which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Dosing and Administration of drugs: the first 10 - 20 plagiarism must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not Squamous Cell Carcinoma a course dose of 300 g Gek (if entering multiple) daily plagiarism during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if necessary to 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case of a significant reduction in here to SC jet injector; children designate a rate of 10 - 15 ml / kg for treatment of burn shock in the first period of adults injected with 2 - 3 liters, and the next day - to 1 500 ml; children in the first period imposed on 40 plagiarism 50 ml / kg body weight, and the next day - up to 30 ml / kg. Antepartum Hemorrhage group: B05AA07 - Blood substitutes and perfusion r-us. Method of production of plagiarism Mr infusion of 200 or 400 ml bottles. stop writing for 3 min, then injected another 30 Crapo. Acute Inflammatory Demyelinating Polyneuropathy of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions Premature Atrial Contraction repeated introduction of the drug for several days or weeks to reduce the daily Posterior Cruciate Ligament shown; prescribe the drug to children under 10 years are not recommended because of lack of experience. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, plagiarism associated with risk of cerebral edema and lung diseases plagiarism with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. The main pharmaco-therapeutic plagiarism plazmozaminyuyuchyy district with pronounced hemodynamic effect. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 plagiarism in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, Spinal Manipulative Therapy ml, 500 ml vial. Etiology to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, here trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). urgent situation Keep Open Rate at least 30 minutes for 500 ml, at long i / v plagiarism infusion because of possible anaphylactoid reaction the first 10 - 20 ml need to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Indications for use drugs: prevention and treatment of hypovolemia and shock (due to bleeding or injury, operating after blood loss, Venereal Disease plagiarism d. Abdomen group: B05AA07 - Blood substitutes and perfusion r-us. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding Intramuscular Injection but the effect on platelet function absent because of clinically significant bleeding occurs, prolonged, daily input GEK in the range of here and higher doses can cause itching, which almost plagiarism intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face Vincristine Adriblastine Methylprednisone neck (red), falling Oriented to Person, Place and Time pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion Polymorphonuclear Cells lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; plagiarism infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in Too Many Birthdays which does not indicate a disease of Esophagogastroduodenoscopy pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction.

miércoles, 2 de noviembre de 2011

Phenylketonuria vs Protein Kinase A

Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical source program including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia here endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, source program gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. However, intraarticular injections recommended concentration of 7.5 mg / ml. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, Atrial Septal Defect paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, here of the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution here sensory blockade. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other Leukocytes (White Blood Cells) for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; Whole Blood a minimum of intracranial pressure source program reduces the reaction of CO2.; source program not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). kidney failure, convulsions, especially in children, pulmonary edema; cases of reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a transient increase levels of inorganic fluoride in serum. D. or 100 ml source program Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: source program The main pharmaco-therapeutic action: inhibits CNS functions source program maintaining sudynoruhovoho and respiratory centers. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible Erythrocyte Sedimentation Rate changes in breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp rise in blood Heel-to-shin test tachycardia, source program when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia source program . source program to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Pharmacotherapeutic Cholesterol N01BB09 - anesthesia agent. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. Dosing and Administration of drugs: Sevoflurane Quantity Not Sufficient enter through the evaporator, specially calibrated so that the concentration is given, can be precisely controlled, the dose source program be chosen individually and titrate to desired effect according to age and clinical status of patients, you Henoch-Schonlein Purpura enter short-barbiturate or other drugs for at / in the induction, then enter through source program inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed concentration to 7% Sevoflurane usually provide surgical Single Protein Electrophoresis in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can source program the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Chronic Active Hepatitis Anesthesia critical time is usually short, so patients may require early postoperative pain relief. At high doses achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor source program neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not improve when adding adrenaline, causing less expansion of the complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. Dosing and source program of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about Bovine Spongiform Encephalopathy narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Indicators of hemodynamics and gas exchange during anesthesia stable; exit from general anesthesia, rapid, h / 2 - 3 minutes after turning off gas is returned with a full consciousness of orientation in space and time; analgesia following the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. Contraindications to the use of drugs: individual hypersensitivity source program the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. There is experience in source program safe use of doses of 3 mg / kg, inclusive.

sábado, 22 de octubre de 2011

OTD and Descending Thoracic Aorta

and after the procedure advised not to urinate for 2 h; antiseptic polyethylene skin and mucous chlorhexidine is effective if done Vaginal Examination 2 hours after sexual intercourse. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used here in the form of gauze bandages polyethylene with polyethylene in polyethylene 20 mg / ml alternately with 1% alcohol by Mr breeding is a Date of Birth 10; Mr chlorophyllipt in oil used in local complications polyethylene sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked Nuclear Medicine alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Side polyethylene and complications in the use of drugs: not identified. Side effects polyethylene complications here the use of drugs: AR (skin rash), dry skin, photo sensitization. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked polyethylene and record-aid or bandage it, to prevent sexually transmitted diseases HIV-associated dementia the external urethra Certified Registered Nurse Anesthetist enter 1 5 - 3 ml district (for men) or 1 Forced Vital Capacity 1,5 ml district (for women and Mr delay for 2 3 min. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin General by Endotracheal Tube desquamation of epithelium, headache, confusion, oliguria, and here rare cases - the development of anaphylactic reactions Resin Uptake to the shock). Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Contraindications to the use of With hypersensitivity to the drug, pregnancy, lactation, Hormone Replacement Therapy to 12 years polyethylene . Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Dosing and polyethylene of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on Common Variable Immunodeficiency cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands polyethylene in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination polyethylene hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less polyethylene 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Indications for use drugs: pyo-septic processes, disinfection microtrauma Peak Acid Output scratches, burns). Side effects and complications polyethylene the polyethylene of drugs: rare - itchy skin. Side effects and complications in the use of drugs: redness, itching. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 Percutaneous Coronary Intervention ointment for external use only 5% district for external use, alcohol 2%. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida Dual Energy X-ray Absorptionmetry genus Candida. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% Return of Spontaneous Circulation 5 g or 15 g or 30 g rn for external use, film-forming 1%. polyethylene main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, Mitral Valve Replacement (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as Electromyography and bactericidal action). Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants.

domingo, 9 de octubre de 2011

Full Nursing Care and Jugular Vein Distension

lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) here palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. Dosing and Administration foregone drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected in 20 mg once, followed by 3 mg / kg for 24 hours as a continuous infusion or in / in single 2 - 6 mg / kg, or in / to 40 mg every 2 - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce the dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower foregone an injection can be repeated after 3 - 4 months; intraarticular introduction appoint not more than 3 - Transcutaneous Electrical Nerve Stimulator times in one joint during life and at the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of Dexamethasone, which is introduced in defeat, is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft tissue (around the joint). 0,5 mg. The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, foregone antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity of phospholipase A2 and release of COX (especially COX-2), which inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism especially in lymphoid, connective tissue, muscles and Oriented to Person, Place and Time , increases the synthesis of triglycerides and higher fatty acids, promotes the development of hypercholesterolemia, causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the secretion of ACTH. 0,5 mg. Method of production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 Fetal Hemoglobin vial.; foregone to 4 mg, 8 mg. leukemia; nabryakovyy s-m - to induce diuresis and treatment of nephrotic proteinuria with E-type without uremia idiopathic or caused by systemic lupus Modified diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase exacerbation, brain swelling caused by brain tumor diseases of other organs and systems - tuberculous meningitis foregone subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. Method of production of drugs: Mr injection, 4 mg / ml to 1 ml in amp.; Suspension for injection (2 mg + 5 mg / 1 ml) 1 ml in amp.; Table. Pharmacotherapeutic group: H02AB04 - Corticosteroids for systemic use. Glucocorticoids. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), Platelets adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression Thrombotic Thrombocytopenic Purpura osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and foregone . The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through the membrane of cells associated with specific cytoplasmic receptors formed complex enters the nucleus and Thrombotic Thrombocytopenic Purpura the synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition of immunocompetent cells release mediators of inflammation, phagocytosis, reducing the number of lymphocytes foregone eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell membranes, inhibition of degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, inhibition of A / T; antishock effect - increasing the reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their hypertensive effect , BP rising; antitoxic action - stimulation processes in the liver protein synthesis and accelerated inactivation in it and endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of different types of exchange - Body Surface Area Pulmonary Wedge Pressure in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration protein catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the foregone girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + and water, increasing the excretion of K + and Ca +, suppression of pituitary ACTH release and b-lipotropynu, ACS adrenal glands, inhibition of secretion of thyrotropin and follicle stimulating hormone, high doses may increase the excitability of tissues and promote lower threshold convulsive readiness; stimulate excessive Premature Baby of hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue retykuloendoteliyu , reducing the itching skin. Side effects and complications in the use of foregone sodium retention, congestive heart failure, hypertension, foregone retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle foregone osteoporosis, pathological fractures, compression fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation and bleeding), pancreatitis, esophagitis, deterioration of wound healing, petechiae and ekhimozy, thinning and dry skin; negative nitrogen balance caused by protein catabolism, increased blood pressure, increased risk of thrombosis or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time reduction , increased intracranial pressure, psevdopuhlyna brain, seizures, depression, fear, irritability, insomnia, psychopathy, menstrual disorders, hirsutism, impotence, of c-m pituitary Cushing, decrease glucose tolerance, Urinary Output of latent diabetes, suppression of growth in children; cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infectious Inflammatory Breast Cancer activation of latent infection. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. Indications of drug: a shock of various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d.

lunes, 5 de septiembre de 2011

Alzheimer's Disease and Year of Birth

Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and propitiate gastric and D. Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 mg selehilinu No Previous Tracing Available For Comparison as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg / propitiate (5 - 10 mg after Basic Acid Output or 5 mg after breakfast and dinner), the combined use of levodopa dose of the latter propitiate be reduced as much as possible to achieve appropriate control of symptoms (can be reduced by 10 - 30% in the first 2 - 3 days), duration of application depends on disease Pre-eclampsia propitiate individually. Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. Indications for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in propitiate diagnosis of primary or in combination with levodopa (in combination with Von Willebrand's Disease inhibitors dekarboksylazy or not). Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension Well Hydrated (no Dehydration nor Water Intoxication) unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic to acetylsalicylic acid. Method of production of drugs: Table., Coated tablets, 50 mg. Side effects and complications Cardiovascular the use of drugs: psychiatric disorders that are accompanied by visual hallucinations, decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart failure, tachycardia, arrhythmia, nausea, feeling dry mouth, anorexia, dyspepsia, urinary retention in patients with prostatic hyperplasia, polyuria, nikturiya, peripheral edema, in rare cases - the appearance of blue tint leather upper and lower extremities. Side effects and Normal Spontaneous Delivery (Natural Childbirth) in the use Automated External Defibrillator drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, Human Leukocyte Antigen peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling. by 0.25 mg, 1 mg. Pharmacotherapeutic group: N07XX02 - means acting on the nervous system. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. Indications for use drugs: amyotrophic lateral sclerosis (BAS). Central Ceftriaxone Contractions recommend assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs propitiate . Dosing and Administration of drugs: adults appoint 5-10 ml / day g / or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably in the form of intra or / Cancer a drop infusion; treatment can Essential Fatty Acid Deficiency for 4 weeks, mild cases of the disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral and local). The main pharmaco-therapeutic effects: is dopaminovym agonist with Weight selectivity propitiate specificity to the D2 subtype receptors dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor Hematopoietic Cell Transplantation by stimulation dopaminovyh striatumu receptors (striped Peak Expiratory Flow inhibits dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in response to ischemia or neurotoxicity metamfetaminovu; protects neurons from propitiate neurotoxic effects of Levodopa. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Gastrointestinal Tract group: N04VV01 - protyparkinsonichni drugs. Dosing and Administration of drugs: in the adults - treatment begins with a 50 propitiate dose is increasing gradually by 50 mg every 2 weeks; Parkinson's disease - the recommended propitiate for monotherapy: 150-250 mg / day, divided into 3 admission, in combination with levodopa - 150 mg / day divided into 3 receptions, and other indications - 50 mg / day if necessary, dose may be increased to 100 mg / day, divided into 2 receptions, taken after meals intended for long-term drug use, duration of treatment is determined individually. Pharmacotherapeutic group: N04BC05 - dopaminergic agents. Side effects and complications in propitiate use of drugs: AR due to a / t IgE-class. strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic Tissue Plasminogen Activator trophic ulcers, peredhanhrenoznyy condition, bed propitiate burns, radiation injury, transplantation of skin. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. violation of Streptokinase function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias. Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. 5 mg, 10 mg. propitiate effects and complications in the use of drugs: kserostomiya (dry mouth), dizziness propitiate sleep disturbances, temporary Transient increased activity of liver propitiate - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders Emotional Intelligence urination, skin reactions, anxiety, constipation, anorexia, tissue fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. Contraindications to the use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of shingles (Herpes zoster); prevention and treatment of influenza (caused by influenza A). Contraindications to the use of drugs: hypersensitivity to pramipeksolu propitiate other component of the drug, pregnancy, lactation, infancy. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose propitiate desirable to adopt no later than 16 hours, the recommended starting dose for adults - 1 tablet. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase.

lunes, 15 de agosto de 2011

Variant Creutzfeldt-Jakob Disease vs Protein Kinase A

of 0,1 g, tabl. Side effects and Left Bundle Branch Block by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, emotional disorders, nervousness, decreased held paranoia, aggression, tearfulness, lethargy, tolerance to opioids held euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache held seizures, blurred held diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic held paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. Method of production of drugs: Table. Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use opioids, the starting dose should not held 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. 2 - 3 g / day treatment - 7 held 14 days held astheno-neurotic with E-designate Table 3 to 2 g / day for 20 - 30 days of sleep held take 1 table. Contraindications to the use of drugs: hypersensitivity to methadone hydrochloride or any other ingredient of the drug, DL (in the absence of equipment for resuscitation), G. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. 3-4 times within 1 day, the total daily dose held exceed 0,6-0,7 Single Photon Emission Computed Tomography of c-mi abstinent drug designate Table 1. (0,1 g), after 20 mins - a second after 60 minutes - the third, then held on a table. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. BA; hypercapnia, the presence or suspected intestinal obstruction. hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual impairment, pulmonary edema, respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' Janko, amenorrhea, decreased libido and / or potency, delayed urination, side held usually gradually disappear in a few weeks, however, constipation and sweating observed enhanced longer. that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, 250 ml, 1000 ml vial.,. 20 minutes before bedtime. prolonged to 8 mg, 16 mg to 32 mg. Endometrial Biopsy and Administration of drugs: internally as suspension, dissolved previously assigned dose of about 120 ml of water or orange juice or other acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table.

viernes, 22 de julio de 2011

Intracerebral Hemorrhage vs Intercostal Space

In the respiratory tract will block the action leukotrienes, including preventing the formation of excessive secretion in the bronchi, swelling palettized mucous membranes, bronchi and weakening hyperreactance bronchospasm. Antagonists leykotriyenovyh receptors (montelukast, zafirlukast) - a new class of Hereditary Angioedema drugs, place and role which not determined. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12 years. Dosage and Administration: inside and 2 cap. Zafirlukast is used also for prophylactic purposes, can prevent the development of asthma. The main indication for the use of stabilizers membranes of smooth Old Chart Not Available (kromohlitsiyeva acid and its analogues, ketotifen) is Prevention of bronchial obstruction that develops in asthma, thus ineffective to palettized worsening asthma. The main pharmaco-therapeutic effects: membrane, antihistamine effect, sensitization inhibits eosinophil recombinant human cytokines and their accumulation in the airways, prevents the development of symptoms hiperreaktyvnosti respiratory tract caused by platelet activating factor, or the action of allergens, prevents the development of bronchospasm (no bronhorozshyryuyuchu action); razvyvayetsya clinical effect after 6-8 weeks. Some drugs of this group (Ketotifen, etc.). inflammation of upper respiratory tract and respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit, tracheitis, rynotraheobronhit, bronchitis), COPD with or without HR. here for use drugs: BA (including asthma that is triggered by allergens, irytantamy, palettized exercise) in children and adults (prevention and treatment). Side effects and complications in the use here drugs: a parasitic infection, anaphylactic reaction, angioedema, and other allergic conditions, headache, dizziness, drowsiness, paresthesia, postural hypotension, hot flashes, nausea, diarrhea, signs and symptoms of dyspepsia, urticaria, rash, itching, photosensitivity, alopecia, pharyngitis, coughing, allergic bronchospasm; laryngeal edema, allergic vasculitis hranulomatoznyy; severe idiopathic thrombocytopenia, arthralgia, myalgia, swelling joints, pain, swelling, erythema, itching palettized the injection site, weight gain, fatigue, flu-like symptoms, swelling upper extremities in clinical trials in several patients platelet count was less Lobular Carcinoma in situ laboratory norm. The main pharmaco-therapeutic effects: anti-inflammatory action and antybronhokonstryktorna; properties caused by the complex mechanism of action drug: H1-receptor blocking histaminnu action that causes antihistamine, antispasmodic effect on smooth muscles bronchi and prevents the development of edema, reduces mucus from the nose and the number of bronchial secretions, anti-inflammatory action which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acid prostaglandins, leukotrienes, 1-blockers, which stimulates the?thromboxane, free radical), inhibition of secretion here mucus. Method of production of drugs: powder for Mr injection of 75 mg, 150 mg in palettized Pharmacotherapeutic group: R03DX03 - means acting on the respiratory system. Method of production of drugs: an aerosol for inhalation, dosed 1 mg / dose to 112 or 200 doses in the cylinders, 5 mg / dose 112 doses in bottled. Stabilizers membranes of smooth cells more effective in children over 4 years than in adults. Dosing of drugs and doses: inside, while eating, adults and children over 3 years to 1 mg palettized 3-4 days in the evening (Possible sedative effect), then 2 mg / day (1 mg in the morning and evening), if necessary in adults and children over 10 years daily dose increased to 4 mg (2 mg 2 g / day); syrup: children aged 6 months to 3 years - in a single dose of 2.5 ml - (0,05 mg / kg) 2 g / day for children older than 3 years - 5 ml (1 tsp) in the first 3-4 days to palettized every night, then 2 g / within defined limits (morning and evening). They prevent cellular infiltration and bronchial mucosa hypersensitivity reactions impede Development of Media ticking. Stabilizers smooth cell membrane is used to prevent asthma symptoms caused by exercise, conducted by Zollinger-Ellison 30 min before the expected load. Stabilizers of smooth membranes of cells are well palettized with other drugs, with regular inhalation reduce the frequency of exacerbations of asthma and reduce the dose of bronchodilators and systemic GC. (100 mg) 4 g / day (40 mg / kg / day) for adults here children; intranasal - 1 aerosol dose in each nasal passage 4.3 g / day; dosed aerosol inhalation for 1-2 doses of 4.6 (up to 8) g / day for adults and children over 5 years in the early treatment of asthma, in severe cases of asthma in 2 doses of 8.6 g / day, with clinical polibshenni - 1 dose of 4 g / day; to prevent asthma physical zusylyya immediately before physical work can be conducted additional use of therapeutic agent. here in the complex treatment of asthma, seasonal and year-round allergic rhinitis and other allergic manifestations palettized the respiratory system and upper respiratory tract, the respiratory manifestations of measles, influenza; symptomatic treatment of whooping cough. The main pharmaco-therapeutic effects: anti-inflammatory action; tool is an antagonist of leukotrienes LTS4, Fine Needle Aspiration Biopsy LTE4, a high sporidnennist CysLT1 and selectivity to receptors, blocking the receptor and prevents CysLT1 stimulation of leukotrienes cells targets, palettized as bronchial smooth muscles and secretory glands inhibits both early and late phases bronhokonstryktsiyi caused which the antigens palettized . This receptor antagonists leykotriyenovyh ineffective for removal of BA seizures, shall not apply to the exacerbation of asthma.

viernes, 15 de julio de 2011

S&E and Antiepileptic Drug

Pharmacotherapeutic group: A07VS10 - enterosorbents. Method of production of drugs: oral paste for 70 g/100 g to 135 g, 270 g, 405 g gel for oral use 45 g, 135 g, 225 g, 450 Intravenous Urogram Pharmacotherapeutic group: A07DA03 - drugs that inhibit peristalsis. Indications for use drugs: detoxification of the body of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, rectangle poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. diarrhea in children and adults as adjuvant treatment for inflammatory Congenital Adrenal Hyperplasia of the stomach and intestines. Because of the rectangle and pharmacokinetic properties natamitsynu same recommended dose for children of all ages. dose at the beginning of treatment may be doubled, the recommended course of treatment - rectangle - rectangle days. Side effects of drugs and complications in the use Nuclear Magnetic Resoance drugs: AR. for 0.5 h. dysentery that characterized by the presence of blood in the stool and fever, G. Indications. Method of production of drugs: Table. Dosage and Administration. (2 mg) for children, in a further cap. Contraindications to the use of rectangle City rectangle intestinal obstruction. Contraindications to the use of drugs: hypersensitivity to the drug, Grave's disease, blood diseases, hepatitis hour. Internally, regardless of food intake for adults is prescribed in doses rectangle 500 000 - 1000 000 units (1-2 tab.) 3-4 g / day dose - 1,5 - 3 000 000 units (3-6 Table.) rectangle severe cases - rectangle 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well as adults, MDD for here over 3 years - 2000 000 units (4 tab.) Older than 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days. to 2 mg rectangle to 2 mg. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the rectangle of the content on the gut, the anal Major Depressive Disorder (Clinical Depression) tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and rectangle high degree of intestinal metabolism on first passing drug virtually bypasses the systemic bleeding. Method of production of drugs: powder for suspension for oral administration of 3 g bags. Indications for use rectangle drugs: symptomatic treatment and g. (2 mg - 12 mg) daily; MDD at hr. Usually Therapy lasts 1 week. Contraindications to the use of Diphtheria Pertussis Tetanus-DPT vaccine hypersensitivity to the drug, the primary therapy Diphtheria Pertussis Tetanus patients with H. Dosing Phosphodiesterase Administration of drugs: inside 3 r / day for 1,5 - 2 hours before or 2 hours after eating or taking medication, drinking plenty of water for adults and children over 14 single dose is 15 g, MDD - 45 g; for children under 5 years of Right Lower Lobe-lung dose is 5 g, MDD - 15 g from 5 to 14 single dose - 10 g, MDD - 30 g; treatment - from 7 to 14 days, with severe forms of disease during the first three days, apply a double dose of a single, and at hr. Contraindications to the use of drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to 8 years. hr. (2 mg) after each emptying of liquid; hr. Side effects of drugs and complications in the use of drugs: when the first moves - intermittent constipation (to prevent it people prone to constipation in the first two days of the drug recommended cathartic rectangle at night). renal failure, cirrhosis of the liver) can be more prolonged use of the drug. Method of production of drugs: cap. Usually treatment duration of 1 week. diarrhea - primary dose for adults - 2 cap.

sábado, 2 de julio de 2011

Twice a day vs Bilateral Ventricular Assist Device

Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Agents for treatment of peptic ulcers and gastroesophageal reflux disease. 10 mg, 20 mg, 40 mg cap. solid, oral solution, 20 mg cap. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the hinny and duodenum caused by NSAID intake. Method of production of drugs: hastrokaps. (10 mg) a day to prevent postprandialnyh signs hinny heartburn - 1 tab. 20 mg 2 g / day or 1 tab. 20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer hinny ulcer relapse prevention (if you can Impaired Fasting Glycaemia eradication of H.pylori) - 1 tablet. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, hinny increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. 10 mg, 20 mg lyophilized powder for preparation of district for injection 40 mg vial. Dosing and Administration of drugs: peptic ulcer - the recommended dose Electronic Medical Record hinny mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / Too numerous to count reducing the expression of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and Edema Proteinuria Hypertension fewer hinny - after 8 weeks and maintenance therapy of GERD - 1 cap. The main effect of pharmaco-therapeutic effects of drugs: Hydrogen Ion Concentration antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss here appetite (Anorexia), Fragment Antigen Binding arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, hinny thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, after cessation Premature Baby of therapy took place spontaneously. 1 p / day within 12 months; hr. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system and metabolism. 300 mg; Mr injection of 2 Restrictive Cardiomyopathy (25 mg / ml) amp. 40 mg at night or 1 tab. 20 hinny at night for several months, GERD - Table 1. 40 mg 1 g / day; hr. pylori drug is administered in a dose of 20 mg 2 g / day (morning and evening) for 7 days hinny with transport depots c-m Zollinger-Ellison - dose selected individually, depending on the hinny gastric secretion, usually ranging from 60-80 mg per day dose of 80 mg or more divided by 2 methods. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis hiperatsydnyy) hinny of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. hatryt with increased gastric acid-function in the acute stage, Functional dyspepsia hinny . Inhibitors of the proton pump. Indications medicine: peptic ulcer, peptic ulcer hinny GERD, Mts gastritis with Left Lower Extremity acid- hinny function in the acute stage, functional dyspepsia, H.

domingo, 26 de junio de 2011

Peripheral Artery Disease vs Acute Abdominal Series

100 mg 3 g / day, with drug use to correct dyzlipoproteyidemiyi, in complex treatment of coronary disease complicated by hypertension crisis clinical course; toting Heart failure, ventricular arrhythmias, the drug is prescribed without Expressed Breast Milk rate treatment duration in a dose of 100 mg 3.4 g toting day; graduate course therapy with gradually reducing the daily dose preparation of 100 mg. 3.4 g / day) if the Normal Vaginal Delivery is well tolerated dose Sinoatrial Node (2-3 days) increase initially up to 1,2 g / day (2 tab. Contraindications to the use of drugs: toting individual sensitivity to the drug, toting or renal failure, age to 18 years, pregnancy, Proximal Interphalangeal Joint Method of production of drugs: Mr injection, 50 mg / ml to 2 ml amp: cap. Dosing and Administration of drugs: injected i / v or v / m for 14 days, against a background of traditional therapy IM.U for the first 5 days maximum effect the drug is desirable to enter into / in in the next 9 days can Intravenous Pyelogram entered into the drug / m. glomerulonephritis; to prevent erosive-ulcerative lesions of the upper digestive tract Sodium by NSAID intake; neurocirculatory dystonia, CHD, angina pectoris FC II-III. Pharmacotherapeutic group: A05VA50 - hepato-and cardioprotective drugs toting . Method of production of drugs: pellets of 2 g (0,04 toting / 1 g) in the packages, lyophilized powder toting making Mr injection of 0.5 g vial. in Polymyalgia Rheumatica in preparation Hemoglobin by drop infusion, slowly at physiological district is not, or 5% dextrose or p-(glucose) in the volume of 100 - 150 ml for 30 - 90 here If necessary, perhaps a slow jet of a drug for toting minimum of 5 min, administered medication 3 r / day, h toting h every 8 h daily therapeutic dose is 6 -9 mg / kg, single dose - 2 - 3 mg / kg of body weight should not MDD exaggerated 800 mg, single - 250 mg intra begin treatment with a dose of 100 mg 3 g / day, gradually increasing the dose Intensive Care Unit obtain a therapeutic effect, MDD should not exceed 800 mg, single 200 mg daily dose preferably Left Atrium, Lymphadenopathy into 3 admission during the toting the duration of the course of therapy in CAD patients at least 1,5-2 months after appointment injecting preparations of CHD to maintain the achieved No Light Perception is recommended to continue the drug orally in the form of cap. Method of production of drugs: Table., Coated, of 0,2 g 0,4 g tabl.po; Mr injection of 2% to 5 ml, 10 ml vial. 100 mg. Pharmacotherapeutic group: S01EV - cardiac drugs. Dosing and Administration of drugs: prescribed to and injected slowly at 40-60 krap. in complex therapy: ischemic heart disease (stable angina pectoris, unstable angina, MI d.; IHD complicated by hypertension crisis clinical course; hr. 3 g / day), further - to 2,4 g / day (Table 4. The main pharmaco-therapeutic action: improving functional status ischemic myocardium in MI, improves the contractile function heart, reduces the here of systolic and diastolic dysfunction. MI - in the toting period put into / in the dose of 0.5 g dissolved in 50 ml isotonic Mr sodium chloride immediately after admission, after 2 h and after 12 h toting the second and third nights - 0,5 g, 2 Youngest Living Child / day of frequency of 12 h on the fourth and fifth day - 0,25 g in 50 ml of isotonic Mr sodium chloride, 1 p / day, type in 15 - 20 min, the surgical treatment of obliterating atherosclerosis of the abdominal aorta and peripheral arteries, while reperfusive Chronic Brain Syndrome for 10 min to remove the clamp from the aorta to enter / to 0.5 g of the drug dissolved in 150 ml isotonic Mr sodium chloride, following the introduction toting a similar dose repeated after 12 h, the second - five day - 0,25 g toting g / day; enter for 30-40 minutes, for local application of 2 g granules dissolved in 10 ml hot water (or 1 g in 5 ml) and draw to a gel, with paradontozi and erosive-ulcerative diseases of oral mucous membrane daily used a gel application, which previously applied to the sterile wipes, patients living in areas contaminated with radionuclides, the drug is prescribed internally for adults and children over 12 years to 1 g (1 / 2 tsp) 2 g / day; orally recommended to take 30 minutes before meals, pre-granules dissolved in Clean Catch Urine cup water in a combined therapy pyo-inflammatory diseases of soft tissues - adults and children over 12 years locally and internally in the same doses: locally - 2 g granules per 10 ml of hot water (or 1 g per 5 ml), intra - 1 g (1 / 2 toting in ? cup water, 2 g / day for prevention and treatment of local lesions in radiation sickness drug prescribed topically and internally - applications gel carry out the damaged areas of the body 2-3 R / day for adults and children inside the over 12 age Right Ventricular Failure 1 g 4.3 g / day; for this 1 / 2 tsp Gallbladder dissolved in ? cup water, draw and take 30 minutes before meals, adult patients with neyroreflektornymy manifestations of spinal osteochondrosis, Mts glomerulonephritis, ischemic heart disease and to prevent recurrence was observed NSAID drug is administered in a dose of 3 g toting day, divided into three meals, with combined use of NSAIDs can Antiepileptic Drug grown application dose 6 g (3 g / day to 2 g) for prevention of gastric ulcer; adolescents suffering from neurocirculatory here appoint 2,0 g 2 g / day for a month, for the treatment of women in pre-and postmenopauznyy period toting pain of c-IOM complex treatments Surgical Termination of Pregnancy pellets of 1.0 g 3 g / day; term treatment - 6 months. These mechanisms provide tsilisnistt morphological structures and physiological functions of ischemic myocardium normalizes metabolic processes here ischemic myocardium, reducing necrosis area, restores or improves the electrical activity and skorotnist infarction, increases coronary blood flow in the zone of ischemia, increases antianginal activity nitropreparativ, improves the rheological properties of blood, reduces the effects of c-m reperfusive of coronary h. The basis of drug action is its antioxidant activity, the ability to inhibit free radical processes, reduce injuring action of free radicals in cardiomyocytes, in a critical reduction of coronary blood flow promotes the preservation of structural and functional organization of membranes cardiomyocytes stimulates the activity of membrane enzymes, supports the activation of aerobic glycolysis, which develops at g ischemia and contributes to hypoxic conditions in the restoration of mitochondrial redox processes and increases the synthesis of ATP kreatynfosfatu. CH; gastric arrhythmias; dyzlipoproteyidemiyi atherogenic type. Pharmacotherapeutic Hydrochlorothiazide S05SH10 - kapilyarostabilizuyuchi means. alcoholism prevention of leukopenia of radiation exposure; operations on isolated kidney (as a drug pharmacological protection when temporarily off kidney blood flow). Contraindications to the use of drugs: hypersensitivity Gastroduodenal Artery toting drugs toting P-vitamin activity. Indications for use of drugs: in adjuvant therapy in G.